Influence of Nonfatal Hospitalization for Heart Failure on Subsequent Mortality in Patients With Chronic Heart Failure
Author(s) -
Scott D. Solomon,
Joanna Dobson,
Stuart J. Pocock,
Hicham Skali,
John J.V. McMurray,
Christopher B. Granger,
Salim Yusuf,
Karl Swedberg,
James B. Young,
Eric L. Michelson,
Marc A. Pfeffer
Publication year - 2007
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.107.696906
Subject(s) - medicine , heart failure , hazard ratio , ejection fraction , cardiology , proportional hazards model , candesartan , confidence interval , blood pressure , renin–angiotensin system
Patients with chronic heart failure (HF) are at increased risk of both fatal and nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) trials to assess the influence of nonfatal hospitalizations for HF on subsequent mortality rates in a broad spectrum of HF patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom